Showing results (31-40 of 136) with videos related to
Sort By:
Pageof 14
Diagnostic Microbiology and Infectious Disease|May 1, 1989
Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosaK E Aldridge, A Henderberg, C V SandersTubercle|September 1, 1978
In vitro sensitivity of Mycobacterium marinum to minocycline and doxycyclineJ R Torres, M Sands, C V SandersCancer Research|February 1, 1977
Inhibition of neutrophil chemotaxis by 4-hydroxycyclophosphamideD N Gilbert, P Starr, N EubanksDiagnostic Microbiology and Infectious Disease|May 1, 1987
RO23-6240, a new orally absorbed quinolone: in vitro comparison with other broad-spectrum oral antimicrobial agents and imipenemK E Aldridge, D D Schiro, C V SandersSouthern Medical Journal|September 1, 1979
Spondylitis caused by Brucella abortusJ Torres-Rojas, R F Taddonio, C V SandersAnnals of Internal Medicine|July 1, 1985
Cefamandole and cefoxitinC V Sanders, R N Greenberg, R L MarierEuropean Journal of Clinical Microbiology|April 1, 1987
Comparative in vitro activity of the new oral cephalosporin BMY-28100K E Aldridge, D D Schiro, C V SandersThe American Journal of the Medical Sciences|March 28, 2001
Allergic bronchopulmonary disease caused by Bipolaris hawaiiensis presenting as a necrotizing pneumonia: case report and review of literatureR E Saenz, W D Brown, C V SandersThe American Review of Respiratory Disease|August 1, 1979
Metronidazole in the treatment of anaerobic infectionsC V Sanders, B J Hanna, A C LewisAntimicrobial Agents and Chemotherapy|January 1, 1982
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteriaD A Martin, C V Sanders, R L MarierPageof 14